Acro Biomedical Co., Ltd.’s Q3 2026 10-Q window runs Nov 2, 2026 to Jan 26, 2027.
Based on 8 prior 10-Q filings.
Acro Biomedical Co., Ltd. · CIK 1622996 · Engraved from SEC EDGAR